About
About
Philosophy
Culture
Transparency
Leadership Team
Partners
History and Global Brand
Sustainability
Innovation
Innovation
Pipeline
Clinical Trials
Investigator Research
Educational Grants
Clinical Trial Data Privacy Policy
Medical Writing Grants
Medical Information
Expanded Access Policy
News
News
News Posts
Social Media Community Guidelines
Products
Investors
Careers
Contact
United States
Worldwide
HOME
News
News
Back number
Please select
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
March
Mar.05, 2024
Release
Shionogi Announces Xocova® (Ensitrelvir Fumaric Acid) Obtained Standard Approval in Japan for the Treatment of SARS-CoV-2 Infection
February
Feb.09, 2024
Release
Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open
Feb.05, 2024
Release
Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramón Polo as Senior Vice President, Head of Regulatory Affairs